MJBizDaily
DEA selects only cannabis foes to participate in marijuana rescheduling hearing
Latest Posts
Trulieve is first US cannabis company to trade on NYSE
CEO Kim Rivers called the listing a turning point for the cannabis sector. Analysts predict the company will break even in the next year.
News June 11
Nabis CEO on the future of interstate cannabis commerce post-rescheduling
Vince Ning says the question of whether reclassifying medical marijuana opens state borders to cannabis products remains largely unsettled.
News June 11
Missouri cannabis sales hit record $135.1 million in May
The average price of cannabis items sold dropped from $28.79 in May 2025 to $26.61 for the same month this year.
News June 10
Cannabis legislation could break Virginia’s budget impasse
Gov. Abigail Spanberger could support folding a regulated adult-use retail framework into the budget after vetoing a standalone sales bill.
News June 9
New Mexico built a successful cannabis market without the hype
New Mexico’s cannabis market is growing. It’s not flashy or headline-grabbing; it’s a steady climb to statewide success.
News June 9
Trulieve to become first US cannabis company listed on NYSE
Trulieve completed a corporate restructuring and that deconsolidated its operations in markets serving both medical and adult-use customers.
News June 8
Will rescheduling revive medical cannabis? It depends on the state
The opportunity is not just tax relief or capital access – it’s rebuilding cannabis around wellness and products tailored to specific needs.
News June 8
Michigan’s cannabis tax gamble comes up short in first quarter
The tax, which kicked in Jan. 1, was at the center of a bipartisan road-funding deal that ended a drawn-out budget standoff last year.
News June 5
DEA registration is a tough choice for medical marijuana operators
Registration provides a safe harbor for medical marijuana businesses, but they must hand over a lot of sensitive information to the agency.
News June 5
Latest Sponsored
